A rule that would set new ceiling prices in the 340B drug discount program has been delayed until mid-2018 while HHS considers alternative regulations.
Receive unlimited access to Modern Healthcare's Research & Data Center with a Premium SubscriptionSubscribe Today
Healthcare news this week …
As policymakers and the drug and device industry look for new ways to bring treatments for life-threatening conditions to the market sooner, providers are concerned that expedited approvals could compromise patient care.
The American Medical Association says doctors and their patients, not pharmacy benefit managers, should determine opioid treatment plans, criticizing Express Scripts' plan to limit the number and strength of opioid drugs prescribed to first-time users.
Bayada Home Health Care described the move to not-for-profit as the first of its kind in the industry, driven by a motivation to sustain the organization for multiple generations and bolster recruiting and retention efforts.
Northwestern Medicine may have found the one hospital market where investment in long-term care hasn't paid off: affluent north suburban Lake Forest, Ill.
A new financial disclosure shows Summa Health lost more than $33 million in the first half of this year, compared with a $14 million profit for the like period last year. Interim CEO Dr. Cliff Deveny previously warned that the system was on track to lose more than $60 million in operating income.
Mylan allegedly misclassified EpiPens as a generic drug, which may have cost the government up to $1.27 billion in lost Medicaid rebates, according to federal estimates.
A leading U.S. hospital pulled its annual fundraiser from Donald Trump's Mar-a-Lago resort on Thursday, reversing course after initially resisting pressure from health professionals and others over the president's support for repealing the Affordable Care Act and cutting federal research dollars.
Chinese billionaire Tianqiao Chen as recently as February used his 10% stake in Legg Mason to gain two board seats at the asset-management firm, including the vice chairmanship for himself. His designs for CHS haven't been made public but he already carries weight with his holdings.
As hackers gain easier access to the tools of their trade, hacks of healthcare organizations have increased dramatically, with 162% more so far in 2017 as there were in all of 2016.
In a 2-1 ruling, a federal appeals court panel ruled that Arkansas can block Medicaid funding to Planned Parenthood, two years after the state ended its contract with the group over videos secretly recorded by an anti-abortion group.
The deal with Centene Corp. in partnership with the Nevada-based Hometown Health will help ensure coverage is available to all Nevadans, after Anthem Blue Cross and Blue Shield pulled out of the state's healthcare exchange.
President Donald Trump says he's ending a pair of White House advisory councils that were staffed by corporate chief executives. Merck and Johnson & Johnson are among the parade of departing leaders from the informal panel.
Longtime UnitedHealth CEO Stephen Hemsley will step down Sept. 1, and President David Wichmann will take over. The change marks a major leadership shakeup at the nation's largest health plan.
Pharmaceuticals take to Facebook, crowdsourced diagnostic tools inspire enthusiasm and skepticism, and the movie "What the Health" bends the truth.
Cincinnati and South Carolina are the latest to sue drug distributors and manufacturers for allegedly fueling the opioid crisis by filling suspicious drug orders. Companies call the efforts "misguided."
The Trump administration's cancellation of two mandatory pay models could signal to providers that they can value volume over quality, experts say.
Naperville, Ill.-based Edward-Elmhurst Health is feeling the squeeze of climbing bad debt thanks to high-deductible health plans, soaring pharmaceutical costs and Medicare and Medicaid reimbursements that don't fully cover the price tag of patient care.
The new money from a Los Angeles-based asset management firm includes equity and debt financing and will be used to buy doctors' practices and open additional outpatient clinics.
For an institution accustomed to securing multimillion-dollar donations, Cleveland Clinic's latest fundraising effort has some relatively small targets: projects up to $10,000.